NeuroBionics | Revolutionizing Neurotechnology & Interfaces
NeuroBionics aims to advance neurotech and human health through bioelectronic medicine, by developing devices that seamlessly integrate with the human body.
Overview
NeuroBionics is a company focused on bioelectronic medicine, headquartered in Somerville, Massachusetts. The company develops implantable devices that interface with the human body using flexible, multifunctional fibers the size of a human hair. These fibers can record and stimulate neural activity, deliver drugs, and ablate tissue. NeuroBionics employs an endovascular approach to navigate its flexible fiber implants through blood vessels, allowing for precise therapeutic interventions to neural tissue. The company aims to make neural interfacing a minimally invasive procedure, which could enhance deep brain stimulation and increase access to this therapy for patients with conditions such as Parkinson's disease, essential tremor, epilepsy, and depression.
Details
- Category
- Biotechnology Research
- Headquarters
- Somerville, Massachusetts
- Type
- Privately Held
- Founded
- 2023
- Followers
- 5,410
- Specialties
- Medical Devices, Neuroscience, Neuromodulation, and Minimally-Invasive
- Locations
- 444 Somerville Ave Somerville, Massachusetts 02143, US
Funding
Total rounds: 5
Last round: Grant, May 14, 2025